Atossa Therapeutics (ATOS)'s 30-day implied volatility (IV30) was 93.1% at the close on October 29, 2026, down from 109.4% the day before, against a 52-week range of 50.7% to 125.2%. Its 20-day historical volatility was 127.2%.
Data as of October 29, 2026.